阿拉斯加州的基金减少了其科利吉亚制药股份2.2%, Alaska's state fund reduced its Collegium Pharmaceutical shares by 2.2%, despite the company's revenue rise.

阿拉斯加州的税务部门在第一季度将专注于治疗疼痛的专业制药公司Collegium Pharmaceutical的股份减少了2.2%,现在拥有价值533,000美元的17870股股票. The State of Alaska Department of Revenue reduced its holdings in Collegium Pharmaceutical, a specialty pharmaceutical company focused on pain management, by 2.2% in the first quarter, now owning 17,870 shares worth $533,000. 公司投资组合包括Xtampza ER和Nucynta ER等产品。 The company's portfolio includes products like Xtampza ER and Nucynta ER. 尽管收入增长了22.7%,达到1.77亿美元,但Collegium略低于每股收益的预期. Despite a 22.7% increase in revenue to $177.76 million, Collegium slightly missed earnings per share expectations.